Search results for "new-drug development"

Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27

Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27

Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's Ministry of Food and Drug Safety...
South Korea to Deploy AI Across Public Health Centers and Ambulances to Close Care Gaps

South Korea to Deploy AI Across Public Health Centers and Ambulances to Close Care Gaps

Artificial intelligence tools that assist in interpreting X-ray images and drafting clinical notes will soon be deployed to public health centers in...
From Retinal Scans to Brain Imaging: South Korea Backs Six Medical AI Tools for Fast-Track Hospital Adoption

From Retinal Scans to Brain Imaging: South Korea Backs Six Medical AI Tools for Fast-Track Hospital Adoption

Medical AI tools designed to assess cardiovascular risk from retinal images and analyze brain scans for stroke severity...
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.
AI Platform Replaces Animal Models to Accelerate Parkinson’s Cell Therapy

AI Platform Replaces Animal Models to Accelerate Parkinson’s Cell Therapy

Researchers are launching an international joint study that leverages artificial intelligence to evaluate whether...
South Korea Overhauls Pharma and Biotech Disclosure Rules Following Samchundang Controversy

South Korea Overhauls Pharma and Biotech Disclosure Rules Following Samchundang Controversy

South Korean financial authorities are overhauling disclosure regulations across the pharmaceutical and biotechnology...
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%

Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%

Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead

Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead

Biogen Korea has appointed Kim Chul-woong as its new general manager, tapping an executive with extensive expertise in...
Unlocking the Mystery of Bladder Pain: Researchers Map Cellular Network Driving Interstitial Cystitis

Unlocking the Mystery of Bladder Pain: Researchers Map Cellular Network Driving Interstitial Cystitis

Sharp, stinging pelvic pain and dozens of exhausting trips to the bathroom in a single day—these are the debilitating...